Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lupus
Biotech
Biogen, UCB report phase 3 lupus win after failing earlier trial
Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners reporting positive data.
Nick Paul Taylor
Sep 24, 2024 6:00am
CAR-T therapy for lupus nets ‘Insight’ prize for researchers
Jun 21, 2024 4:30am
Cell therapy reckoning: An unmet need remains in oncology
May 30, 2024 10:00am
How 'remarkable' results in lupus carried CAR-T to immunology
May 30, 2024 9:00am
Takeda culls cancer, gut and inflammation drugs in R&D rethink
May 9, 2024 5:13am
Roivant's inflammatory med is back on track with ph. 2 NIU data
Apr 2, 2024 10:37am